PharMerica CORP Increase (Decrease) in Accounts Receivable
PharMerica CORP reported Increase (Decrease) in Accounts Receivable of $2.60 million for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2017-11-09
- PharMerica CORP increase (decrease) in accounts receivable for the quarter ending 2017-09-30 was $2.60M, a 64.86% decline year-over-year.
- PharMerica CORP increase (decrease) in accounts receivable for the quarter ending 2017-06-30 was -$1.20M, a 115.00% decline year-over-year.
- PharMerica CORP increase (decrease) in accounts receivable for the quarter ending 2017-03-31 was $5.30M.
- PharMerica CORP increase (decrease) in accounts receivable for the quarter ending 2016-12-31 was $19.90M, a 452.78% increase year-over-year.
- PharMerica CORP increase (decrease) in accounts receivable for fiscal 2016 was $34.30M, a 1329.17% increase from fiscal 2015.
- PharMerica CORP increase (decrease) in accounts receivable for fiscal 2015 was $2.40M.
- PharMerica CORP increase (decrease) in accounts receivable for fiscal 2014 was -$29.10M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2017-09-30 | $2.60M 10-Q · filed 2017-11-09 | $1.40M derived: sum of 2 quarters · filed 2017-11-09 | $6.70M 10-Q · filed 2017-11-09 | $26.60M derived: sum of 4 quarters · filed 2017-11-09 |
| 2017-06-30 | -$1.20M 10-Q · filed 2017-08-02 | $4.10M 10-Q · filed 2017-08-02 | $24.00M derived: sum of 3 quarters · filed 2017-08-02 | $31.40M derived: sum of 4 quarters · filed 2017-11-09 |
| 2017-03-31 | $5.30M 10-Q · filed 2017-05-10 | $25.20M derived: sum of 2 quarters · filed 2017-05-10 | $32.60M derived: sum of 3 quarters · filed 2017-11-09 | $40.60M derived: sum of 4 quarters · filed 2017-11-09 |
| 2016-12-31 | $19.90M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $27.30M derived: sum of 2 quarters · filed 2017-11-09 | $35.30M derived: sum of 3 quarters · filed 2017-11-09 | $34.30M 10-K · filed 2017-02-24 |
| 2016-09-30 | $7.40M 10-Q · filed 2017-11-09 | $15.40M derived: sum of 2 quarters · filed 2017-11-09 | $14.40M 10-Q · filed 2017-11-09 | $18.00M derived: sum of 4 quarters · filed 2017-11-09 |
| 2016-06-30 | $8.00M 10-Q · filed 2017-08-02 | $7.00M 10-Q · filed 2017-08-02 | $10.60M derived: sum of 3 quarters · filed 2017-08-02 | $7.20M derived: sum of 4 quarters · filed 2017-08-02 |
| 2016-03-31 | -$1.00M 10-Q · filed 2017-05-10 | $2.60M derived: sum of 2 quarters · filed 2017-05-10 | -$800.00K derived: sum of 3 quarters · filed 2017-05-10 | |
| 2015-12-31 | $3.60M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $200.00K derived: sum of 2 quarters · filed 2017-02-24 | $2.40M 10-K · filed 2017-02-24 | |
| 2015-09-30 | -$3.40M 10-Q · filed 2016-11-09 | -$1.20M 10-Q · filed 2016-11-09 | ||
| 2014-12-31 | -$29.10M 10-K · filed 2017-02-24 |